Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)
Clinical trial NCT06250400 · UNKNOWN
Trial details
- NCT number
- NCT06250400
- Sponsor
- Hangzhou Grand Biologic Pharmaceutical, Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-31
- Primary completion
- 2025-07-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.